Keros Therapeutics shares owned by Ensign Peak Advisors
Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Ensign Peak Advisors
from 13F filings
Historical chart of Ensign Peak Advisors investment in Keros Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Keros Therapeutics held by Ensign Peak Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Keros Therapeutics by Ensign Peak Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $4.2M | 72k | 58.07 |
| 2024-06-30 | $3.3M | 72k | 45.70 |
| 2024-03-31 | $4.7M | 72k | 66.20 |
| 2022-09-30 | $90k | 2.4k | 37.82 |
| 2022-06-30 | $66k | 2.4k | 27.73 |
| 2022-03-31 | $129k | 2.4k | 54.20 |
| 2021-12-31 | $139k | 2.4k | 58.40 |